Vaxxinity Inc (NASDAQ:VAXX)’s traded shares stood at 0.34 million during the last session, with the company’s beta value hitting 2.39. At the close of trading, the stock’s price was $0.72, to imply an increase of 4.14% or $0.03 in intraday trading. The VAXX share’s 52-week high remains $3.10, putting it -330.56% down since that peak but still an impressive 22.22% since price per share fell to its 52-week low of $0.56. The company has a valuation of $90.94M, with an average of 0.26 million shares in intraday trading volume over the past 10 days and average of 410.78K shares over the past 3 months.
Vaxxinity Inc (NASDAQ:VAXX) trade information
After registering a 4.14% upside in the last session, Vaxxinity Inc (VAXX) has traded red over the past five days. The stock hit a weekly high of 0.7500, jumping 4.14% in its intraday price action. The 5-day price performance for the stock is 1.11%, and -10.81% over 30 days. With these gigs, the year-to-date price performance is -15.59%. Short interest in Vaxxinity Inc (NASDAQ:VAXX) saw shorts transact 3.85 million shares and set a 4.78 days time to cover.
Vaxxinity Inc (VAXX) estimates and forecasts
Looking at statistics comparing Vaxxinity Inc share performance against respective industry, we note that the company has underperformed competitors. Vaxxinity Inc (VAXX) shares are -50.86% down over the last 6 months, with its year-to-date growth rate lower than industry average at 6.67% against 12.70%. Revenue is forecast to grow 37.50% this quarter before jumping 33.30% for the next one.
VAXX Dividends
Vaxxinity Inc has its next earnings report out between May 07 and May 13. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Vaxxinity Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Vaxxinity Inc (NASDAQ:VAXX)’s Major holders
Vaxxinity Inc insiders hold 50.92% of total outstanding shares, with institutional holders owning 12.30% of the shares at 25.06% float percentage. In total, 12.30% institutions holds shares in the company, led by Adage Capital Partners GP L.L.C.. As of Dec 30, 2023, the company held over 3.0 million shares (or 2.66% of shares), all amounting to roughly $2.15 million.
The next major institution holding the largest number of shares is Blackrock Inc. with 2.71 million shares, or about 2.40% of shares outstanding. As of the market price on Dec 30, 2023, these shares were worth $1.95 million.
We also have Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF as the top two Mutual Funds with the largest holdings of the Vaxxinity Inc (VAXX) shares. Going by data provided on Dec 30, 2023, Vanguard Total Stock Market Index Fund holds roughly 1.49 million shares. This is just over 1.32% of the total shares, with a market valuation of $1.07 million. Data from the same date shows that the other fund manager holds a little less at 1.05 million, or 0.93% of the shares, all valued at about 0.76 million.
